- Home
- ALG vs VKTX Comparison
ALG vs VKTX Comparison
Compare ALG & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALG
- VKTX
- Stock Information
- Founded
- ALG 1955
- VKTX 2012
- Country
- ALG United States
- VKTX United States
- Employees
- ALG N/A
- VKTX N/A
- Industry
- ALG Industrial Machinery/Components
- VKTX Biotechnology: Pharmaceutical Preparations
- Sector
- ALG Industrials
- VKTX Health Care
- Exchange
- ALG Nasdaq
- VKTX Nasdaq
- Market Cap
- ALG 2.6B
- VKTX 2.8B
- IPO Year
- ALG 1993
- VKTX 2015
- Fundamental
- Price
- ALG $223.11
- VKTX $27.11
- Analyst Decision
- ALG Buy
- VKTX Buy
- Analyst Count
- ALG 2
- VKTX 12
- Target Price
- ALG $186.00
- VKTX $84.00
- AVG Volume (30 Days)
- ALG 156.8K
- VKTX 3.7M
- Earning Date
- ALG 07-30-2025
- VKTX 07-23-2025
- Dividend Yield
- ALG 0.55%
- VKTX N/A
- EPS Growth
- ALG N/A
- VKTX N/A
- EPS
- ALG 9.60
- VKTX N/A
- Revenue
- ALG $1,593,877,000.00
- VKTX N/A
- Revenue This Year
- ALG $0.52
- VKTX N/A
- Revenue Next Year
- ALG $5.01
- VKTX N/A
- P/E Ratio
- ALG $22.77
- VKTX N/A
- Revenue Growth
- ALG N/A
- VKTX N/A
- 52 Week Low
- ALG $157.07
- VKTX $18.92
- 52 Week High
- ALG $220.00
- VKTX $81.73
- Technical
- Relative Strength Index (RSI)
- ALG 67.07
- VKTX 46.50
- Support Level
- ALG $215.42
- VKTX $26.20
- Resistance Level
- ALG $219.85
- VKTX $28.20
- Average True Range (ATR)
- ALG 3.77
- VKTX 1.53
- MACD
- ALG -0.47
- VKTX -0.06
- Stochastic Oscillator
- ALG 84.50
- VKTX 38.15
About ALG Alamo Group Inc.
Alamo Group Inc is engaged in the design, manufacture, and servicing of high-quality vegetation management and infrastructure maintenance equipment for governmental, industrial and agricultural use. Its products include tractor-mounted and self-propelled mowers, zero-turn mowers, agricultural implements, tree and branch chippers, forestry/wood recycling equipment, street and parking lot sweepers, leaf and debris collection equipment, truck mounted highway attenuator trucks, vacuum trucks, hydro-excavation equipment, telescopic boom excavators, and snow removal equipment. The company's reportable segments are Vegetation Management and Industrial Equipment. It generates a majority of revenue from Vegetation Management. Geographically, it generates the majority of revenue from United States.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.